Clinical trials
Completed Phase 4 Angina Pectoris trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aarhus University Hospital Skejby | 2 |
| Foundation of Cardiovascular Research and Education Enschede | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| AstraZeneca | 1 |
| Aultman Health Foundation | 1 |
| Burnasyan Federal Medical Biophysical Center | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Deutsches Herzzentrum Muenchen | 1 |
| Frisch Medical Device Private Limited | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina Pectoris | 30 |
| Coronary Artery Disease | 12 |
| Atherosclerosis | 5 |
| Coronary Disease | 5 |
| Angina, Stable | 4 |
| Myocardial Infarction | 4 |
| Angina, Unstable | 3 |
| Coronary Stenosis | 3 |
| Acute Coronary Syndrome | 2 |
| Cardiovascular Diseases | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.